US Approves Remediesivir for Kovid Treatment Drug maker Gilead claims that Redeemer is the only drug currently available to treat hospitalized patients with Kovid.
Authorities say the redesign was approved after several clinical trials. The drug should be used only in children over 12 years old and weighing more than 40 kg. However, in emergency situations, the drug can also be used in children under 12 years of age. They must weigh at least 3.5 kg.
In addition to RemDesivir, some other drugs are licensed in the US Licenses for these drugs are likely to change in order for Kovid to proliferate.
Gilead shares rose sharply on the New York Stock Exchange following the news.
History highlights – US gives full approval to Remdesivir